PD-1 blockers have proved to be an effective deterrent in slowing the progress of mesothelioma. In the course of studying PD-1 inhibitors, researchers in Italy and the Netherlands found that the positive impact of this promising treatment was elevated among patients taking statin drugs for the treatment of high cholesterol.
In analyzing outcomes, the researchers noted that of the 253 patients enrolled in the study, some were on statin drugs to control their high cholesterol levels. The mesothelioma patients who were treated with both PD-1 blockers and cholesterol drugs experienced slower disease progression than those on the PD-1 blockers alone. Further, those on higher doses of statins experienced the longest survival times.
If you or a loved one has been diagnosed with mesothelioma as a result of exposure to asbestos, contact the experienced attorneys at Nass Cancelliere. For more than 35 years, the Philadelphia-based law firm of NASS CANCELLIERE has represented more than 4,000 people who have contracted MESOTHELIOMA and other forms of asbestos-related illness. Our attorneys have tried over 1,000 cases throughout Pennsylvania and New Jersey and we have collected over $500 million for our clients. Learn more by calling 215-546-8200 to speak with an attorney or contacting us online.